Previous Article | Next Article ![]()
Journal of Bacteriology, June 2009, p. 3928-3937, Vol. 191, No. 12
0021-9193/09/$08.00+0 doi:10.1128/JB.00290-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Uwe Remminghorst,
Irfan Ahmad,
Katherina Zakikhany, and
Ute Römling*
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Received 4 March 2009/ Accepted 8 April 2009
The bacterial second messenger cyclic di-GMP (c-di-GMP) regulates the transition between sessility and motility. In Salmonella enterica serovar Typhimurium, the expression of CsgD, the regulator of multicellular rdar morphotype behavior, is a major target of c-di-GMP signaling. CsgD expression is positively regulated by at least two diguanylate cyclases, GGDEF domain proteins, and negatively regulated by at least four phosphodiesterases, EAL domain proteins. Here, we show that in contrast to EAL domain proteins acting as phosphodiesterases, the EAL-like protein STM1344 regulated CsgD expression positively and motility negatively. STM1344, however, did not have a role in c-di-GMP turnover and also did not bind the nucleotide. STM1344 acted upstream of the phosphodiesterases STM1703 and STM3611, previously identified to participate in CsgD downregulation, where it repressed their expression. Consequently, although STM1344 has not retained a direct role in c-di-GMP metabolism, it still participates in the regulation of c-di-GMP turnover and has a role in the transition between sessility and motility.
Published ahead of print on 17 April 2009.
Present address: Laboratory for Microbial Dynamics, Department of Pharmaceutical Biosciences, University of Oslo, Oslo, Norway.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»